A team of Spanish researchers has claimed that applying the same dose in the body rather than two doses of the same antidote creates a more effective defense against coronavirus. However, the Center said that although it is theoretically possible in this regard, no such move is being considered in the near future as no research has been done on it in India.
A study by Spanish researchers on the effects of combination drugs was published in the May 19 issue of the journal Nature. In Spain, 63 volunteers developed antibodies to Oxford-AstraZeneca and Pfizer-Biotech. Volunteers were first vaccinated with the Oxford-AstraZeneca vaccine. Two-thirds of these volunteers were given the Pfizer-biotech vaccine eight weeks later. Applying a single dose of another antidote was found to have created a strong and effective immunity against the corona virus in the volunteer body. Those who received two different doses of the drug had their bodies produce more antibodies than the others, and those antibodies were able to detect and inactivate the corona virus. Researchers have previously been successful in using this ‘mix and match’ strategy against the Ebola virus.
